Nothdurfter, Caroline

Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects

Rupprecht, R., Rammes, G., Eser, D., Baghai, T. C., Schüle, C., Nothdurfter, C., Troxler, T., Gentsch, C., Kalkman, H. O., Chaperon, F., et al. (2009) · Science

Pharmacological Receptor Mechanisms and EffectsNeuroscience and Neuropharmacology Research

Cited by 328

Tryptophan Metabolism and Immunogenetics in Major Depression: A Role for Interferon-γ Gene

Myint, A. M., Bondy, B., Baghai, T. C., Eser, D., Nothdurfter, C., Schüle, C., Zill, P., Müller, N., Rupprecht, R., & Schwarz, M. J. (2013) · Brain, Behavior, and Immunity

Tryptophan and brain disordersTreatment of Major Depression

Cited by 74

Impact of Lipid Raft Integrity on 5-HT3 Receptor Function and its Modulation by Antidepressants

Nothdurfter, C., Tanasic, S., Di Benedetto, B., Rammes, G., Wagner, E.-M., Kirmeier, T., Ganal, V., Kessler, J. S., Rein, T., Holsboer, F., et al. (2010) · Neuropsychopharmacology

Neuroscience and Neuropharmacology ResearchLipid Membrane Structure and Behavior

Cited by 43

The Cytokine IL-17A as a Marker of Treatment Resistance in Major Depressive Disorder?

Nothdurfter, C., Milenkovic, V. M., Sarubin, N., Hilbert, S., Manook, A., Weigl, J., Almeqbaali, K., Wetzel, C. H., Rupprecht, R., & Baghai, T. C. (2021) · European Journal of Neuroscience

Tryptophan and brain disordersTreatment of Major Depression

Cited by 38

Computer-assisted avatar-based treatment for dysfunctional beliefs in depressive inpatients: A pilot study

Kocur, M., Dechant, M., Wolff, C., Nothdurfter, C., Wetter, T. C., Rupprecht, R., & Shiban, Y. (2021) · Frontiers in Psychiatry

Digital Mental Health InterventionsAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 15